J.G.M. van Engelen

455 total citations
11 papers, 334 citations indexed

About

J.G.M. van Engelen is a scholar working on Health, Toxicology and Mutagenesis, Cancer Research and Dermatology. According to data from OpenAlex, J.G.M. van Engelen has authored 11 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Health, Toxicology and Mutagenesis, 4 papers in Cancer Research and 3 papers in Dermatology. Recurrent topics in J.G.M. van Engelen's work include Effects and risks of endocrine disrupting chemicals (6 papers), Carcinogens and Genotoxicity Assessment (4 papers) and Pharmaceutical studies and practices (3 papers). J.G.M. van Engelen is often cited by papers focused on Effects and risks of endocrine disrupting chemicals (6 papers), Carcinogens and Genotoxicity Assessment (4 papers) and Pharmaceutical studies and practices (3 papers). J.G.M. van Engelen collaborates with scholars based in Netherlands, United States and Switzerland. J.G.M. van Engelen's co-authors include Adriënne J.A.M. Sips, Carolien Versantvoort, Esther Brandon, C.J.M. Rompelberg, Agnes G. Oomen, Gerhard Heinemeyer, Carlos Rodríguez, Gerrit Wolterink, L.L. de Zwart and Bas Bokkers and has published in prestigious journals such as Environment International, Toxicology and Applied Pharmacology and Regulatory Toxicology and Pharmacology.

In The Last Decade

J.G.M. van Engelen

11 papers receiving 313 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.G.M. van Engelen Netherlands 10 167 70 55 53 33 11 334
Cian O’Mahony Ireland 11 146 0.9× 96 1.4× 64 1.2× 33 0.6× 67 2.0× 29 419
Juan-Carlos Carrillo Netherlands 11 130 0.8× 98 1.4× 30 0.5× 29 0.5× 46 1.4× 30 399
Joseph Melendres United States 11 147 0.9× 146 2.1× 97 1.8× 61 1.2× 13 0.4× 18 445
Falko Partosch Germany 11 159 1.0× 21 0.3× 49 0.9× 39 0.7× 20 0.6× 16 309
Lena Sedik United States 10 146 0.9× 111 1.6× 76 1.4× 58 1.1× 9 0.3× 12 348
Melissa Vincent United States 13 195 1.2× 27 0.4× 58 1.1× 41 0.8× 110 3.3× 38 541
Daniel Bury Germany 18 349 2.1× 97 1.4× 68 1.2× 164 3.1× 21 0.6× 45 657
T. Ichinose Japan 6 165 1.0× 27 0.4× 34 0.6× 35 0.7× 26 0.8× 7 387
B.H. Woollen United Kingdom 15 148 0.9× 72 1.0× 321 5.8× 92 1.7× 22 0.7× 26 697
Gerry M. Henningsen United States 13 274 1.6× 14 0.2× 50 0.9× 212 4.0× 35 1.1× 23 532

Countries citing papers authored by J.G.M. van Engelen

Since Specialization
Citations

This map shows the geographic impact of J.G.M. van Engelen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.G.M. van Engelen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.G.M. van Engelen more than expected).

Fields of papers citing papers by J.G.M. van Engelen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.G.M. van Engelen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.G.M. van Engelen. The network helps show where J.G.M. van Engelen may publish in the future.

Co-authorship network of co-authors of J.G.M. van Engelen

This figure shows the co-authorship network connecting the top 25 collaborators of J.G.M. van Engelen. A scholar is included among the top collaborators of J.G.M. van Engelen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.G.M. van Engelen. J.G.M. van Engelen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Dudzina, Tatsiana, Christiaan Delmaar, Jacqueline W.H. Biesterbos, et al.. (2015). The probabilistic aggregate consumer exposure model (PACEM): Validation and comparison to a lower-tier assessment for the cyclic siloxane D5. Environment International. 79. 8–16. 38 indexed citations
2.
Rustemeyer, Thomas, Pieter Jan Coenraads, Ron A. Tupker, et al.. (2013). Results of a cosmetovigilance survey in The Netherlands. Contact Dermatitis. 68(3). 139–148. 36 indexed citations
3.
Brandon, Esther, Astrid S. Bulder, J.G.M. van Engelen, et al.. (2013). Does EU legislation allow the use of the Benchmark dose (BMD) approach for risk assessment?. Regulatory Toxicology and Pharmacology. 67(2). 182–188. 12 indexed citations
4.
Bokkers, Bas, et al.. (2012). First tier modeling of consumer dermal exposure to substances in consumer articles under REACH: A quantitative evaluation of the ECETOC TRA for consumers tool. Regulatory Toxicology and Pharmacology. 65(1). 79–86. 13 indexed citations
5.
Engelen, J.G.M. van, Gerhard Heinemeyer, & Carlos Rodríguez. (2007). Consumer exposure scenarios: development, challenges and possible solutions. Journal of Exposure Science & Environmental Epidemiology. 17(S1). S26–S33. 27 indexed citations
6.
Engelen, J.G.M. van, et al.. (2006). General fact sheet - Limiting conditions and reliability, ventilation, room size, body surface area. Updated version for ConsExpo 4. Rivm Repository (Netherlands National Institute for Public Health and the Environment). 23 indexed citations
7.
Brandon, Esther, Agnes G. Oomen, C.J.M. Rompelberg, et al.. (2005). Consumer product in vitro digestion model: Bioaccessibility of contaminants and its application in risk assessment. Regulatory Toxicology and Pharmacology. 44(2). 161–171. 101 indexed citations
8.
Pohl, Hana R., J.G.M. van Engelen, J. Deanna Wilson, & Adriënne J.A.M. Sips. (2005). Risk assessment of chemicals and pharmaceuticals in the pediatric population: A workshop report. Regulatory Toxicology and Pharmacology. 42(1). 83–95. 9 indexed citations
9.
Zwart, L.L. de, et al.. (2004). Role of biokinetics in risk assessment of drugs and chemicals in children. Regulatory Toxicology and Pharmacology. 39(3). 282–309. 48 indexed citations
10.
Engelen, J.G.M. van, et al.. (1997). Effect of Coexposure to Methyl Ethyl Ketone (MEK) onn-Hexane Toxicokinetics in Human Volunteers. Toxicology and Applied Pharmacology. 144(2). 385–395. 18 indexed citations
11.
Engelen, J.G.M. van, et al.. (1995). Determination of 2,5-hexanedione, a metabolite of n-hexane, in urine: evaluation and application of three analytical methods. Journal of Chromatography B Biomedical Sciences and Applications. 667(2). 233–240. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cian O’Mahony Breakdown of academic impact, for papers by Juan-Carlos Carrillo Breakdown of academic impact, for papers by Joseph Melendres Breakdown of academic impact, for papers by Falko Partosch Breakdown of academic impact, for papers by Lena Sedik Breakdown of academic impact, for papers by Melissa Vincent Breakdown of academic impact, for papers by Daniel Bury Breakdown of academic impact, for papers by T. Ichinose Breakdown of academic impact, for papers by B.H. Woollen Breakdown of academic impact, for papers by Gerry M. Henningsen
Rankless by CCL
2026